Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

ClinicalTrials.gov ID: NCT02013544

Public ClinicalTrials.gov record NCT02013544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to confirm the efficacy of intravaginal prasterone (DHEA) on symptoms of vulvovaginal atrophy due to menopause and to collect further data on subjects exposed to intravaginal DHEA in order to meet the ICH E1 guideline requirements.

Study identification

NCT ID
NCT02013544
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
EndoCeutics Inc.
Industry
Enrollment
558 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2014 (Type not available)
Primary completion
Jan 2015 (Actual)
Completion
Feb 2015 (Actual)
Last update posted
Jun 1, 2017

2014 – 2015

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
EndoCeutics site # 39 Montgomery Alabama 36117 —
EndoCeutics site # 14 Tucson Arizona 85712 —
EndoCeutics site # 21 Sacramento California 95821 —
EndoCeutics site # 83 San Diego California 92103 —
EndoCeutics site # 30 San Diego California 92108 —
EndoCeutics site # 36 Denver Colorado 80209 —
EndoCeutics site # 52 Denver Colorado 80220 —
EndoCeutics site # 45 Boynton Beach Florida 33472 —
EndoCeutics site # 60 Lake Worth Florida 33461 —
EndoCeutics site # 54 North Miami Florida 33161 —
EndoCeutics site # 80 West Palm Beach Florida 33409 —
EndoCeutics site # 23 Atlanta Georgia 30328 —
EndoCeutics site # 55 Wichita Kansas 67226 —
EndoCeutics site # 86 Louisville Kentucky 40291 —
EndoCeutics site # 27 Lutherville Maryland 21093 —
EndoCeutics site # 87 Lawrenceville New Jersey 08648 —
EndoCeutics site # 81 Plainsboro New Jersey 08536 —
EndoCeutics site # 05 Cleveland Ohio 44122 —
EndoCeutics site # 15 Columbus Ohio 43213 —
EndoCeutics site # 75 Philadelphia Pennsylvania 19114-1029 —
EndoCeutics site # 84 Corpus Christi Texas 78414 —
EndoCeutics site # 82 Houston Texas 77030 —
EndoCeutics site # 03 Norfolk Virginia 23507 —
EndoCeutics site # 76 Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02013544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2017 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02013544 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →